Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Completed × Hypomagnesemia × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 1709 Neoplasms 1344 Prostatic Neoplasms 671 Colorectal Neoplasms 645 Lung Neoplasms 517 Motor Activity 350 Head and Neck Neoplasms 298 Colonic Neoplasms 274 Uterine Cervical Neoplasms 266 Pain 223 Pancreatic Neoplasms 217 Rectal Neoplasms 193 Anxiety Disorders 191 Carcinoma, Non-Small-Cell Lung 188 Carcinoma, Hepatocellular 181 Ovarian Neoplasms 170 Fatigue 169 Stomach Neoplasms 168 Polycystic Ovary Syndrome 168 Precursor Cell Lymphoblastic Leukemia-Lymphoma 152 Brain Neoplasms 152 Urinary Bladder Neoplasms 146 Melanoma 142 Neoplasm Metastasis 141 Depression 137 Lymphoma 122 Multiple Myeloma 121 Esophageal Neoplasms 120 Obesity 112 Lymphoma, Follicular 111

Interventions

magnesium citrate 1 Magnesium Oxide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02690012 2019-09-06

OTT 15-03

Ottawa Hospital Research Institute

Phase NA Completed

Hypomagnesemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡